세계의 심혈관 스텐트 시장 예측(2025-2030년)

The Cardiovascular Stent Market is projected to rise from USD 12.913 billion in 2025 to USD 18.018 billion in 2030, driven by a 6.89% compound annual growth rate (CAGR).

The global cardiovascular stent market is poised for growth, driven by the rising prevalence of cardiovascular diseases and an aging population requiring interventions for coronary artery blockages. These stents restore blood flow in narrowed or blocked arteries, reducing risks of heart attacks and strokes, thereby improving patient quality of life. However, challenges such as the risk of blood clot formation post-stent placement and the availability of alternative treatments like bypass surgery pose significant constraints to market expansion.

Market Drivers

Rising Cardiovascular Disease Prevalence

The surge in cardiovascular diseases, the leading global cause of death, significantly drives demand for cardiovascular stents. The World Health Organization reports that these diseases account for 32% of annual deaths worldwide, equating to approximately 17.9 million fatalities. In the United States, the Centers for Disease Control and Prevention note that 655,000 deaths occur annually due to heart-related issues, while in Australia, cardiovascular conditions affect over 4 million people, claiming 118 lives daily. Lifestyle factors, including stress, poor dietary habits, and sedentary work cultures, exacerbate these conditions, increasing artery blockages and the need for stents to restore blood flow. This trend is expected to fuel market growth through 2030 as the incidence of cardiovascular issues continues to rise.

Growing Geriatric Population

The expanding geriatric demographic is a key market driver, as older individuals are more prone to cardiovascular conditions requiring stents for effective blood flow management. The United Nations projects that the global population aged 65 and above will reach 15% by 2050, up from 9.5% in 2020. This demographic shift heightens the demand for stents, as age-related artery failures necessitate interventions to maintain cardiovascular health, significantly contributing to market expansion.

Market Constraints

Risk of Blood Clots and Alternative Treatments

A major limitation is the risk of blood clot formation post-stent implantation, which can disrupt blood flow and elevate the risk of heart attacks or strokes. Research indicates that 1-2% of stent recipients develop clots, particularly in the initial months post-procedure, with risks persisting long-term despite preventive measures. Additionally, alternative treatments like bypass surgery challenge market growth. For patients with multiple artery blockages, bypass surgery is often recommended over stents due to lower clot risks and better long-term outcomes. A study by the American College of Cardiology found that 29.87% of stent patients died within 10 years compared to 24.7% of bypass surgery patients, with stroke or heart attack due to clots as the primary cause. Furthermore, 16.1% of stent patients required a second procedure, compared to 8% for bypass patients, highlighting bypass surgery's superior efficacy.

Market Outlook

The cardiovascular stent market is set to grow through 2030, driven by increasing cardiovascular disease prevalence and an aging population. However, the risk of clots and competition from bypass surgery necessitate advancements in stent technology to enhance safety and efficacy. Stakeholders must focus on innovation to address these challenges and capitalize on the growing demand for minimally invasive cardiovascular solutions.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Type

• Dual Therapy Stent
• Bare Metal Stent
• Drug Eluting Stent
• Others

By Material

• Polymers
• Metal
• Stainless Steel
• Cobalt Chromium
• Others

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CARDIOVASCULAR STENT MARKET BY TYPE

• 5.1. Introduction
• 5.2. Dual Therapy Stent
• 5.3. Bare Metal Stent
• 5.4. Drug Eluting Stent
• 5.5. Others

6. GLOBAL CARDIOVASCULAR STENT MARKET BY MATERIAL

• 6.1. Introduction
• 6.2. Polymers
• 6.3. Metal
  • 6.3.1. Stainless Steel
  • 6.3.2. Cobalt Chromium
  • 6.3.3. Others

7. GLOBAL CARDIOVASCULAR STENT MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Ambulatory Surgical Centers
• 7.4. Others

8. GLOBAL CARDIOVASCULAR STENT MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Taiwan
  • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Abbott Laboratories
• 10.2. Medtronic
• 10.3. Boston Scientific Corporation
• 10.4. B. Braun
• 10.5. Terumo Corporation
• 10.6. BIOTRONIK SE & Co. KG
• 10.7. MicroPort Scientific Corporation
• 10.8. Translumina
• 10.9. Integer Holdings Corporation
• 10.10. HEXACATH

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key benefits for the stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations